Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing

Go back to Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing
(NASDAQ: LEXX) Delayed: 4.07 +0.04 (0.99%)
Previous Close $4.03    52 Week High $ 
Open $4.01    52 Week Low $ 
Day High $4.30    P/E N/A 
Day Low $3.88    EPS $ 
Volume 32,368